GL1X · GenesisL1 explorer

MolNFT v1 · #118544 · protein

Structure of E.COLI glpg complexed with peptidic inhibitor ac-vrma-cho

5F5B · Rhomboid protease glpg: “Structure of E.COLI glpg complexed with peptidic inhibitor ac-vrma-cho”. X-ray diffraction, 1 ligand (ACE), 1 pocket (best druggability 0.36). MolNFT v1 #118544 on GenesisL1: 3D structure, binding sites and…

PDB
5F5B
Type
protein
Length
186 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Rhomboid protease glpg; Peptidic derivative of gurken: ACE-val-arg-met-ala- aldehyde
EC
3.4.21.105
UniProt
A0A0J2E248
Ligands
ACE
Pockets
1 · best druggability 0.36

Structure

x-ray diffraction · 2 distinct chains · 73% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARhomboid protease glpg (EC 3.4.21.105)protein18274% helix, 2% strandA0A0J2E248
BPeptidic derivative of gurken: ACE-val-arg-met-ala- aldehydeprotein40% helix, 50% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1840.360.7517empty

Interfaces

1 interface between chains.

  • A–B · 481 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent, 1 modified (covalent ligand, nonstandard).

Compared structures

  • 5F5B · Structure of E.Coli GlpG complexed with peptidic inhibitor Ac-VRMA-CHO · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.